Snowball logo
logo
CYVN

Ceryvyn Therapeutics Limited

CYVNY • OTCMKTS
$0.023-$0.001  (4.17%)
Estimate
P/E
0
EPS
1.36
Beta
1.489
About the company
Ticker
CYVNY
ISIN
Country
Australia
Sector (GICS)
Healthcare
Ceryvyn Therapeutics Limited, a biopharmaceutical company, develops biologic therapy for the rare disease lymphangioleiomyomatosis in Australia. The company offers CYV-101, which is in pre-clinical trial stage, an inhaled therapy intended for delivery directly to the lung. It serves the biotechnology and healthcare industries. The company was formerly known as Opthea Limited and changed its name to Ceryvyn Therapeutics Limited in July 2026. Ceryvyn Therapeutics Limited was incorporated in 1984 and is headquartered in Hawthorn East, Australia.

Frequently asked questions

What sector does Ceryvyn Therapeutics Limited (CYVNY) operate in?

Ceryvyn Therapeutics Limited belongs to the Healthcare sector and operates in the Biotechnology industry.

What is Ceryvyn Therapeutics Limited (CYVNY) current stock price?

As of the latest data, Ceryvyn Therapeutics Limited stock price is $0.02, with a previous close of $0.02. Ceryvyn Therapeutics Limited lost -$0.00 in the last trading session, representing a -4.17% loss.

What is Ceryvyn Therapeutics Limited (CYVNY) current market capitalization?

Ceryvyn Therapeutics Limited market cap is approximately 3.93 million.

What is Ceryvyn Therapeutics Limited (CYVNY) Earnings Per Share (EPS)?

The trailing EPS is $1.36.

What is Ceryvyn Therapeutics Limited (CYVNY) Price-to-Earnings (P/E) ratio?

Ceryvyn Therapeutics Limited current P/E ratio is 0.02.

Does Ceryvyn Therapeutics Limited (CYVNY) pay dividends?

No. Ceryvyn Therapeutics Limited does not pay a dividend.

What is Ceryvyn Therapeutics Limited (CYVNY) beta (volatility) score?

Ceryvyn Therapeutics Limited has a beta of 1.489, suggesting it is more volatile than the market.